[Does an additional administration of acetylsalicylic acid reduce the requirement of betamimetics in tocolytic treatment? (author's transl)].
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002584:Cervix Uteri; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage*; D006801:Humans; D009756:Nylidrin / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D005280:Fenoterol; D009756:Nylidrin; D001241:Aspirin
Ist durch Azetylsalizylsäure eine Verminderung der Beta-Mimetika-Dosis bei der Tokolyse möglich?